Accredited official statistics

MRSA bacteraemia: annual data

Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The following data is included in the latest annual publication for MRSA bacteraemia.

From September 2023

Results by NHS organisation and sub-integrated care board location (SICBL)

  • financial year counts and rates of聽C. difficile聽infection and by prior trust exposure from April 2007 to March 2023
  • financial year counts and rates of MRSA bacteraemia and by onset status from April 2007 to March 2023

From September 2021

Results by NHS organisation

  • financial year counts and rates of MRSA bacteraemia and by onset status from April 2007 to March 2021

From July 2018

Results by post infection review (PIR) assignment

  • quarterly counts of MRSA bacteraemia from April 2013 to March 2018 - PIR trust assigned cases only (table 1a)
  • quarterly counts of MRSA bacteraemia from April 2013 to March 2018 - PIR clinical commissioning group (CCG) assigned cases only (table 1b)
  • financial year counts and rates of MRSA bacteraemia from April 2013 to March 2018 - PIR trust assigned cases only (table 2a)
  • financial year counts and rates of MRSA bacteraemia from April 2013 to March 2018 - PIR CCG assigned cases only (table 2b)

Results by NHS acute trust

  • quarterly counts of MRSA bacteraemia by NHS acute trust and by onset status from April 2007 to March 2018 (table 3)
  • financial year counts and rates of MRSA bacteraemia and by onset status from April 2007 to March 2018 (table 4)

Results by CCG

  • quarterly counts of MRSA bacteraemia by clinical commissioning group (CCG) and by onset status from April 2009 to March 2018 (table 5)
  • financial year counts and rates of MRSA bacteraemia by clinical commissioning group (CCG) and by onset status from April 2009 to March 2018 (table 6)

For commentary on this data see MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection: annual epidemiological commentary.

From July 2014

Results by PIR assignment

  • quarterly counts of MRSA bacteraemia from April 2013 to March 2017 - PIR trust assigned cases only (table 1a)
  • quarterly counts of MRSA bacteraemia from April 2013 to March 2017 - PIR CCG assigned cases only (table 1b)
  • financial year counts and rates of MRSA bacteraemia from April 2013 to March 2017 - PIR trust assigned cases only (table 2a)
  • financial year counts and rates of MRSA bacteraemia from April 2013 to March 2017 - PIR CCG assigned cases only (table 2b)

Results by NHS acute trust

  • quarterly counts of MRSA bacteraemia from April 2007 to March 2017 - all reported cases (table 3a)
  • quarterly counts of MRSA bacteraemia from April 2008 to March 2017 - trust apportioned cases only (table 3b)
  • financial year counts and rates of MRSA bacteraemia from April 2007 to March 2017 - all reported cases (table 4a)
  • financial year counts and rates of MRSA bacteraemia from April 2008 to March 2017 - trust apportioned cases only (table 4b)

Results by CCG

  • quarterly counts of MRSA bacteraemia from April 2009 to March 2017 (table 5)
  • financial year counts and rates of MRSA bacteraemia from April 2009 to March 2017 (table 6)

For older MRSA tables, see the .

Updates to this page

Published 10 July 2014
Last updated 26 September 2024 show all updates
  1. Added annual data for the financial year April 2023 to March 2024.

  2. Added annual data for the financial year April 2022 to March 2023.

  3. Added annual data for the financial year April 2021 to March 2022.

  4. Added annual data for the financial year April 2020 to March 2021.

  5. Added annual data for the financial year April 2019 to March 2020.

  6. Added annual data for the financial year April 2018 to March 2019.

  7. Added annual data for the financial year April 2017 to March 2018.

  8. Added annual data for the financial year April 2016 to March 2017.

  9. Added annual data for the financial year April 2015 to March 2016.

  10. Annual data for the financial year April 2014 to March 2015 added.

  11. First published.

Sign up for emails or print this page